FDA Inspection 1253435 — Mylan Laboratories Limited (FDF-2)

Mylan Laboratories Limited (FDF-2) — FEI 3008316970

The FDA completed an inspection of Mylan Laboratories Limited (FDF-2) on Feb 3, 2023 in Chhatrapati Sambhajinagar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 3, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chhatrapati Sambhajinagar (India)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.